Company: INTS
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001567264-25-000010
Chunk: 35

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 35
---
icitStockholders’ Equity (Deficiency)SharesAmountSharesAmountSharesAmountSharesAmountBalances at December 31, 20225,000,000$10,000 1,449,113$- 1,800,606$- 3,410,103$- $23,555 $(38,653)$(15,098)Issuance of common stock in public offering for cash, net of $3,403 issuance costs-- -- -- 4,485,0001 19,022 - 19,023  Issuance of warrants underwriters in connection with public offering -- -- -- -- 1,170 - 1,170  Conversion of preferred stock into common stock (5,000,000)(10,000)(1,449,113)- (1,800,606)- 4,124,851- 10,000 - 10,000  Conversion of convertible notes into common stock -- -- -- 1,399,716- 6,998 - 6,998  Issuance of warrants to convertible note holders -- -- -- -- 159 - 159  Exercise of options -- -- -- 25,000- 50 - 50  Deemed dividend -- -- -- 264,707- 1,324 (1,324)-  Stock-based compensation expense -- -- -- -- 1,398 - 1,398  Net loss -- -- -- -- (10,538)(10,538)Balances at December 31, 2023-$- -$- -$- 13,709,377$1 $63,676 $(50,515)$13,162  Issuance of common stock in registered direct offering, net of $321 issuance costs -- -- -- 1,237,1131 1,360 - 1,361  Issuance of warrants in registered direct offering, net of $252 issuance costs -- -- -- -- 1,068 - 1,068  Issuance of common stock in ATM offering, net of $82 issuance costs -- -- -- 51,820- 150 - 150  Issuance of common stock in exchange for services -- -- --